Project Grant R01AI189819
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $439,375 Project Grant to the University of California, San Diego (UCSD) on February 19, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research and development of novel genetic control technologies targeting Aedes aegypti mosquitoes, which transmit dengue, chikungunya, and zika viruses. The project focuses on creating female-killing...
- Federal Grant Award Summary Texas A&M University received a $411,704 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 13, 2026, with a completion date of January 31, 2028. The award funds research investigating the dietary regulation of sleep in the disease vector mosquito Aedes aegypti, with particular focus on how blood feeding influences sleep patterns and the...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Washington a $458,849 Project Grant (CFDA 93.855: Allergy and Infectious Diseases Research) effective August 1, 2025, through July 31, 2030, to conduct research on the sensory mechanisms by which disease-vector mosquitoes, specifically Aedes aegypti, detect and locate human blood. The research will employ innovative genetic technologies, including CRISPR/Cas9 gene...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston University Medical Campus a $449,625 Project Grant on July 8, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to advance research on arthropod-borne viral transmission mechanisms. This two-year project, concluding July 7, 2027, will deliver a novel preclinical research model designed to better understand how mosquito feeding and arthropod-mediated...
- Federal Grant Award Summary Yale University received a $192,364 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 4, 2025, with a completion date of July 31, 2030. The grant funds research investigating the impact of antimalarial medications on malaria parasite selection and drug resistance development within mosquito vectors. The research employs experimental models combining...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego $588,514 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 21, 2025, with a completion date of June 30, 2030. This project grant funds the development of novel mosquito control technologies targeting Aedes aegypti, a primary vector for disease transmission. The research will generate conditional and female-lethal gene...
- Federal Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded Boston University a $1.47 million Project Grant under the Trans-NIH Research Support program (CFDA 93.310) effective September 1, 2025 through August 31, 2028. This award supports fundamental neuroscience research investigating how the Aedes aegypti mosquito brain processes human odor cues to locate and bite human hosts. The research deliverables include identification of neurons encoding human...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $2.18 million Project Grant effective November 1, 2025 through October 31, 2029 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate chemosensory mechanisms driving malaria transmission by the African malaria mosquito Anopheles gambiae. The research will identify specific volatile organic compounds (VOCs) in human body odor that...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Indiana University Indianapolis a Project Grant totaling $433,303 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 18, 2025, with a completion date of May 31, 2027. The award funds research and development of an innovative mosquito control technology utilizing RNA interference (RNAi)-based gene silencing to combat mosquito-borne infectious diseases. The primary...
- Federal Grant Award Summary Texas A&M University System Health Science Center received a $423,125 Project Grant award dated July 17, 2025, from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research extending through June 30, 2027. The project focuses on developing an intein-based QF2 (quinic acid-inducible) system for controllable protein expression in the nervous system of Aedes aegypti...
Award Details: Brandeis University received a $779,825 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 18, 2026, with a completion date of January 31, 2031. Products and Services: The grant supports fundamental research investigating the molecular and cellular basis of circadian rhythms in disease-vector mosquitoes, specifically Anopheles gambiae (malaria vector) and Aedes aegypti (dengue vector). The research will identify and molecularly characterize clock neurons and core clock genes (including PER, CLK, TIM, M-CRY, and D-CRY) through creation of genetic knockin lines and single-cell RNA sequencing analyses. The project will generate a comprehensive cellular atlas of circadian neurons in both mosquito species, determine how disruptions in core clock genes affect molecular properties and neuron function, and examine the role of clock genes in peripheral tissues and sensory transduction. By elucidating how circadian mechanisms regulate mosquito blood-feeding behavior, this research will advance understanding of the biological factors underlying disease transmission and inform potential intervention strategies for malaria and dengue control.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $779.8k | 2/18/26 |